Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/6/25 16:37 | 5/6/25 | CYTK | Health | Drug | Pharmaceutical Preparations | Malik Fady Ibraham | CA | O | EVP Rese | 9 | S.d | -1,139 | 42.07 | 0 | -27 | 140 | D | |||||||||||||||
5/5/25 18:21 | 5/5/25 | CYTK | Health | Drug | Pharmaceutical Preparations | Callos Andrew | CA | O | EVP,Chie | 8 | S.d | -2,681 | 43.32 | 0 | -62 | 68 | D | |||||||||||||||
4/29/25 16:33 | 4/29/25 | CYTK | Health | Drug | Pharmaceutical Preparations | Blum Robert I | CA | DO | P,CEO | 8 | S | -4,870 | 42.96 | 0 | -113 | 432 | D | |||||||||||||||
4/21/25 17:42 | 4/21/25 | CYTK | Health | Drug | Pharmaceutical Preparations | Wierenga Wendall | CA | D | 1 | S.d | -769 | 38.46 | 0 | -20 | 25 | D | ||||||||||||||||
4/16/25 16:25 | 4/15/25 | CYTK | Health | Drug | Pharmaceutical Preparations | Henderson John T | CA | D | 1 | S.d | -123 | 38.66 | 0 | -3 | 66 | D | ||||||||||||||||
4/4/25 16:10 | 4/3/25 | CYTK | Health | Drug | Pharmaceutical Preparations | Harrington Robert Arthur | CA | D | 2 | S | -56 | 41.48 | 0 | -1 | 15 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |